Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Tomomi, Oka"'
Autor:
Ryosuke Naka, Tadakazu Kondo, Masashi Nishikubo, Hiroyuki Muranushi, Yasunori Ueda, Tomomi Oka, Fumiya Wada, Junya Kanda, Shohei Yamamoto, Mitsumasa Watanabe, Shinri Okada, Kazunori Imada, Yukiharu Nakabo, Yu Mizutani, Yasuhito Nannya, Seishi Ogawa, Takayuki Ishikawa
Publikováno v:
HemaSphere, Vol 7, p e8463360 (2023)
Externí odkaz:
https://doaj.org/article/27af9106d0ff440db83f6c969b03091f
Autor:
Asami Kataoka, Chisaki Mizumoto, Junya Kanda, Makoto Iwasaki, Maki Sakurada, Tomomi Oka, Masakazu Fujimoto, Yosuke Yamamoto, Kohei Yamashita, Yasuhito Nannya, Seishi Ogawa, Akifumi Takaori-Kondo
Publikováno v:
International Journal of Hematology. 117:919-924
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by UBA1 somatic mutations and is characterized by late-onset systemic autoimmune inflammation and blood abnormalities such as cytopenia, vacuolation of myeloid/erythr
Autor:
Kazunori Toratani, Mizuki Watanabe, Junya Kanda, Tomomi Oka, Mizuki Hyuga, Yasuyuki Arai, Makoto Iwasaki, Maki Sakurada, Yasuhito Nannya, Seishi Ogawa, Takahiro Yamada, Akifumi Takaori-Kondo
Publikováno v:
International Journal of Hematology.
Autor:
Masayuki Inoue, Ayako Kimura, Tomomi Oka, Aya Yajima, Yudai Higuchi, Tatsuki Endo, Hideki Watanabe, Hiroshi Nakagomi, Toshio Oyama
Publikováno v:
Int Cancer Conf J
Neo-adjuvant chemotherapy (NAC) has become a standard treatment for advanced breast cancer because of the advantage of monitoring drug sensitivity and enabling breast-conserving therapy. The changes during NAC are also important to know the biologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a550d36eacee102b39bb5cb2cf033fa
https://europepmc.org/articles/PMC9522963/
https://europepmc.org/articles/PMC9522963/
Publikováno v:
Journal of Infection and Chemotherapy. 27:755-758
Varicella zoster virus (VZV) reactivates more frequently in immunocompromised patients than immunocompetent subjects and is a significant cause of morbidity and mortality. Acyclovir is frequently used for treatment against VZV reactivation. However,
Autor:
Masayuki Inoue, Ayako Kimura, Tomomi Oka, Aya Yajima, Yudai Higuchi, Tatsuki Endo, Hideki Watanabe, Hiroshi Nakagomi
Publikováno v:
Int Cancer Conf J
The benefit of home parenteral nutrition (HPN) for patients with malnutrition due to peritoneal metastasis depends on the type of cancer. During the period 1999–2020, we treated 460 patients with metastatic and stage 4 breast cancer, 23 of whom wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f902513b07d5fd783f62965ed3c66f0
https://europepmc.org/articles/PMC8938569/
https://europepmc.org/articles/PMC8938569/
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(12)
An 83-year-old man was diagnosed with hairy cell leukemia (HCL). He was treated with cladribine and achieved partial remission. However, pancytopenia due to HCL bone marrow involvement progressed slowly. Nine years later, he developed rectal cancer.
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(4)
A 64-year-old man presented with abnormal imaging results on 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET), showing moderately increased FDG-uptake in the entire bone marrow. Blood tests revealed leukocytosis, thrombocytosis, and incr
Autor:
Hironori Haga, Yasuyuki Otsuka, Momoko Nishikori, Akifumi Takaori-Kondo, Tomomi Oka, Takayuki Ishikawa, Toshiyuki Kitano
Publikováno v:
Clinical Case Reports
Key Clinical Message We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non‐nodal, indolent MCL patients may progress after such an e
Autor:
Hiroshi Kawabata, Mari Fujita, Akifumi Takaori-Kondo, Tadakazu Kondo, Kimiko Yurugi, Tomomi Oka, Hideyo Hirai, Kohei Yamashita, Toshiyuki Kitano, Taira Maekawa, Masakatsu Hishizawa
Publikováno v:
Internal Medicine
Autoimmune neutropenia (AIN) is a rare disorder that may cause life-threatening infections. In adults, most cases are secondary to other pathological conditions, and primary AIN is extremely rare. We herein report a case involving a 57-year-old woman